Sonia Liliana Betancourt Cuellar MD, Presenter: Nothing to Disclose

Diana Maria Palacio MD, Abstract Co-Author: Nothing to Disclose

Marcelo Kuperman Benveniste MD, Abstract Co-Author: Nothing to Disclose

Brett Wilson Carter MD, Abstract Co-Author: Author, Reed Elsevier Consultant, St. Jude Medical, Inc

Patricia Monique de Groot MD, Abstract Co-Author: Nothing to Disclose

Jeremy J. Erasmus MD, Abstract Co-Author: Nothing to Disclose

By reading this exhibit the learner should accomplish: 1. An improved understanding of the limitations of the TNM-7 for the staging of NSCLC 2. A greater awareness of the imaging pitfalls encountered in TNM staging and the clinical implications of the mis-interpretation of these findings 3. A clinical and imaging approach to clarify imaging pitfalls that can impact staging and patient management  

Describe and illustrate the limitations of staging as they pertain to the primary tumor, nodal metastasis and M1 a and M1b metastatic disease Describe and illustrate imaging pitfalls as they pertain to the primary tumor, nodal metastasis and M1a and M1b metastatic disease   Review appropriate use of different imaging modalities including MRI and PET-CT and invasive procedures including EBUS to clarify limitations and potential imaging pitfalls that are encountered during the evaluation of patients with NSCLC and can result in inaccurate TNM staging  

http://abstract.rsna.org/uploads/2014/14003875/14003875_idln.pdf

Betancourt Cuellar, S, Palacio, D, Benveniste, M, Carter, B, de Groot, P, Erasmus, J, Lung Cancer: Limitations and Imaging Pitfalls in Multimodality Staging.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14003875.html